Moleculin Biotech (MBRX) Receivables - Other (2019 - 2026)
Moleculin Biotech (MBRX) posted quarterly Receivables - Other of $7000.0 for Q4 2025, down 65.0% year-over-year from $20000.0 in Q4 2024, and up 250.0% quarter-over-quarter from $2000.0 in Q3 2025.
Moleculin Biotech (MBRX) Receivables - Other (2019 - 2026) Analysis & Trends
Moleculin Biotech's Receivables - Other history runs 7 years deep, the most recent figure standing at $7000.0 for Q4 2025.
- In Q4 2025, Receivables - Other fell 65.0% year-over-year to $7000.0; the TTM figure through Dec 2025 stood at $7000.0 (down 65.0% YoY), while the FY2025 annual figure was $7000.0, down 65.0% from the prior year.
- Receivables - Other for Q4 2025 stood at $7000.0, up from $2000.0 in the prior quarter.
- The five-year high for Receivables - Other was $95000.0 in Q4 2023, with the low at $1000.0 in Q2 2025.
- The 5-year median for Receivables - Other is $7000.0 (2023), against an average of $16769.2.
- The sharpest annual moves came in 2022 and 2023: Receivables - Other sank 91.3% in 2022, then surged 4650.0% in 2023.
- Moleculin Biotech's Receivables - Other stood at $23000.0 in 2021, then slumped by 91.3% to $2000.0 in 2022, then soared by 4650.0% to $95000.0 in 2023, then slumped by 78.95% to $20000.0 in 2024, then tumbled by 65.0% to $7000.0 in 2025.
- Business Quant data shows MBRX's Receivables - Other at $7000.0 in Q4 2025, $2000.0 in Q3 2025, and $1000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Moleculin Biotech | 3.35 Mn | 3.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Jun 30, 2026 | 4,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Dec 31, 2023 | 95,000.00 |
| Dec 31, 2023 | 95,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |